Cargando…

Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma

There are associations between DNA methylation and the expression of long non-coding RNA (lncRNA), also known as lncRNA expression quantitative trait methylations (lnc-eQTMs). Lnc-eQTMs may induce a wide range of carcinogenesis pathways. However, lnc-eQTMs have not been globally identified and studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiaohong, Gao, Yue, Bu, Jianlong, Deng, Lin, Zhang, Pinyi, Chi, Meng, Jiang, Lihua, Shi, Xiaoding, Ning, Shangwei, Wang, Guonian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756030/ https://www.ncbi.nlm.nih.gov/pubmed/33362860 http://dx.doi.org/10.3389/fgene.2020.602035

Ejemplares similares

Upregulation of μ-Opioid Receptor in the Rat Spinal Cord Contributes to the α2-Adrenoceptor Agonist Dexmedetomidine-Induced Attenuation of Chronic Morphine Tolerance in Cancer Pain
por: Zhang, Pinyi, et al.
Publicado: (2020)

Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2
por: Chi, Meng, et al.
Publicado: (2020)

Erratum to dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2
por: Chi, Meng, et al.
Publicado: (2020)

Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas
por: Mao, Kaimin, et al.
Publicado: (2023)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma
por: Cai, Wenhan, et al.
Publicado: (2022)

Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer: a single-center study in China
por: Jianlong, Bu, et al.
Publicado: (2021)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
por: Xu, Liexi, et al.
Publicado: (2022)

An Effective Hypoxia-Related Long Non-Coding RNA Assessment Model for Prognosis of Lung Adenocarcinoma
por: Li, Yuanshuai, et al.
Publicado: (2022)

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data
por: Qiu, Wang-Ren, et al.
Publicado: (2022)

Comparative analyses of salivary exosomal miRNAs for patients with or without lung cancer
por: Liu, Mengfeng, et al.
Publicado: (2023)

m(6)A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Wang, Hongbo, et al.
Publicado: (2021)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

MeImmS: Predict Clinical Benefit of Anti-PD-1/PD-L1 Treatments Based on DNA Methylation in Non-small Cell Lung Cancer
por: Shang, Shipeng, et al.
Publicado: (2021)

Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma
por: Zheng, Zhiyuan, et al.
Publicado: (2021)

Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis
por: Liu, Cheng, et al.
Publicado: (2020)

A novel m7G methylation–related signature associated with chromosome homeostasis in patients with lung adenocarcinoma
por: Tao, Xiaoying, et al.
Publicado: (2022)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

Refined expression quantitative trait locus analysis on adenocarcinoma at the gastroesophageal junction reveals susceptibility and prognostic markers
por: Zhong, Ce, et al.
Publicado: (2023)

Integrated Analysis Reveals the Potential Significance of HDAC Family Genes in Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma
por: Wang, Suyu, et al.
Publicado: (2022)

m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)

Enhancer-associated regulatory network and gene signature based on transcriptome and methylation data to predict the survival of patients with lung adenocarcinoma
por: Huang, Shihao, et al.
Publicado: (2022)

Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma
por: Zeng, Jie, et al.
Publicado: (2023)

Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
por: Mo, Zhuomao, et al.
Publicado: (2020)

Clinical relevance of RNA editing profiles in lung adenocarcinoma
por: Shi, Si, et al.
Publicado: (2023)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis
por: Li, Rang, et al.
Publicado: (2021)

Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma
por: Zhang, Hao, et al.
Publicado: (2020)

Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma
por: Zhao, Huihui, et al.
Publicado: (2022)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Role of Non-Coding RNAs in Post-Transcriptional Regulation of Lung Diseases
por: Soni, Dharmendra Kumar, et al.
Publicado: (2021)

Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease
por: Sato, Takashi, et al.
Publicado: (2014)

PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma
por: Long, Huan-ping, et al.
Publicado: (2020)

Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma
por: Zhang, Yuchu, et al.
Publicado: (2021)

Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e7r88dvve8lqcad8gjttstuefr